We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
1826
Ionis Pharmaceuticals
IONS
$9.39B
$395K ﹤0.01%
7,817
-109
-1% -$5.22K
CCRN
1827
DELISTED
Cross Country Healthcare
CCRN
$394K ﹤0.01%
17,390
AMLX icon
1828
Amylyx Pharmaceuticals
AMLX
$2.6B
$393K ﹤0.01%
26,712
TOST icon
1829
Toast
TOST
$19.7B
$392K ﹤0.01%
21,479
-59,350
-73% -$973K
RAPT
1830
DELISTED
RAPT Therapeutics
RAPT
$391K ﹤0.01%
1,969
BGS icon
1831
B&G Foods
BGS
$291M
$391K ﹤0.01%
37,274
CNXN icon
1832
PC Connection
CNXN
$2.03B
$391K ﹤0.01%
5,816
NBR icon
1833
Nabors Industries
NBR
$1.33B
$391K ﹤0.01%
4,786
IMXI icon
1834
International Money Express
IMXI
$353M
$390K ﹤0.01%
17,650
ARCT icon
1835
Arcturus Therapeutics
ARCT
$223M
$389K ﹤0.01%
12,327
PKST
1836
DELISTED
Peakstone Realty Trust
PKST
$388K ﹤0.01%
19,448
REX icon
1837
REX American Resources
REX
$1.44B
$387K ﹤0.01%
16,362
RVNC
1838
DELISTED
Revance Therapeutics, Inc.
RVNC
$387K ﹤0.01%
43,980
ENTG icon
1839
Entegris
ENTG
$24.6B
$386K ﹤0.01%
3,225
-60
-2% -$6.09K
TILE icon
1840
Interface
TILE
$2.23B
$386K ﹤0.01%
30,592
NXRT
1841
NexPoint Residential Trust
NXRT
$631M
$385K ﹤0.01%
11,179
-1,000
-8% -$31.2K
PRM icon
1842
Perimeter Solutions
PRM
$5.66B
$385K ﹤0.01%
+83,635
New +$321K
ETD icon
1843
Ethan Allen Interiors
ETD
$575M
$384K ﹤0.01%
12,043
GRAB icon
1844
Grab
GRAB
$15.1B
$382K ﹤0.01%
113,500
SLP icon
1845
Simulations Plus
SLP
$371M
$382K ﹤0.01%
8,535
FCEL icon
1846
FuelCell Energy
FCEL
$1.63B
$382K ﹤0.01%
7,950
+820
+12% +$31.4K
HOV icon
1847
Hovnanian Enterprises
HOV
$793M
$381K ﹤0.01%
2,450
IMAX icon
1848
IMAX
IMAX
$2.81B
$379K ﹤0.01%
25,248
VERV
1849
DELISTED
Verve Therapeutics
VERV
$377K ﹤0.01%
27,058
GDYN icon
1850
Grid Dynamics Holdings
GDYN
$632M
$376K ﹤0.01%
28,241

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.